Patent Expiry
ITRMF: ORLYNVAH: recorded patent 12544337 expiry
December 23, 2039 · PROBENECID; SULOPENEM ETZADROXIL. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- December 23, 2039
- Company
- Iterum Therapeutics plc (ITRMF)
- Drug
- PROBENECID; SULOPENEM ETZADROXIL
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Patent Expiry
ORLYNVAH: recorded patent 12544337 expiry
Orange Book application NDA213972, product 001, listed patent 12544337 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source
- Drug
- PROBENECID; SULOPENEM ETZADROXIL